Separately, Mizuho cut SYSMEX CORP/ADR from a buy rating to a neutral rating in a research note on Tuesday, November 26th.
SSMXY opened at $35.06 on Friday. SYSMEX CORP/ADR has a 12 month low of $22.01 and a 12 month high of $37.26. The stock has a market capitalization of $14.47 billion, a price-to-earnings ratio of 38.95 and a beta of 0.37. The business has a fifty day moving average price of $33.68 and a 200 day moving average price of $33.47.
Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; systems for high-volume testing in labs; and hematology analyzers for animals.
Further Reading: Stocks Increasing Dividends
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for SYSMEX CORP/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SYSMEX CORP/ADR and related companies with MarketBeat.com's FREE daily email newsletter.